This course aims to improve learner competence and performance for scientists to more accurately design clinical trials and for radiologists to more accurately interpret clinical trials based imaging studies.
Imaging Biomarkers in Clinical Trials: Current Practice & Future TrendsDate: 04/27/2012 - 04/28/2012
Imaging biomarkers serve as important endpoints for clinical trials in the approval process for therapeutic drugs. Various criteria have been developed for objective interpretation of imaging studies. Additionally, there are emerging imaging techniques that have the potential for applications as surrogate endpoints for clinical trials. In this program, taking place April 27 and 28, 2012, at Mass General, we will review the current practice of imaging biomarkers in clinical trials in oncology, cardiovascular, metabolic, bone and joint diseases. Additionally, we will highlight advanced imaging techniques that have potential as surrogate biomarkers.
(Presentations will be posted on the above page when the event takes place.)
O'Keeffe Auditorium, Massachusetts General Hospital